Michael A. Mussallem, Chairman & CEO at Edwards Lifesciences Corp (EW), sold 49,250 shares at $87.14 ($3.5M) on 2022-06-14, disclosed to the SEC on 2022-06-14.
Seasonal sale ($3.5M) by Chairman & CEO — this insider has traded EW in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 9,500 | $0 | 0.0% |
| 2 | $86.24 | 6,714 | $579K | 16.8% |
| 3 | $86.24 | 6,714 | $579K | 16.8% |
| 4 | $87.14 | 10,107 | $881K | 25.5% |
| 5 | $87.14 | 10,107 | $881K | 25.5% |
| 6 | $87.92 | 3,054 |
| $269K |
| 7.8% |
| 7 | $87.92 | 3,054 | $269K | 7.8% |
| Total | $70.18 avg | 49,250 | $3.5M | 100% |
| Filing → |
| EW | SELL | 2024-03-04 | $3.7M | — | Filing → |
| EW | SELL | 2024-02-05 | $5.0M | — | Filing → |
| EW | SELL | 2024-01-05 | $2.3M | — | Filing → |